Macrophages and angiogenesis

Macrophages are supposed to play a key role in inflammatory and tumor angiogenesis. Their importance derives from (1) their ubiquitous presence in normal and especially inflamed tissues, (2) their potential to become activated in response to appropriate stimuli, and (3) their repertoire of secretory products. By release of proteases, growth factors (bFGF, GM‐CSF, TGF‐α, IGF‐I, PDGF, VEGF/VPF, TGF‐β), and other monokines (IL‐1, IL‐6, IL‐8, TNF‐α, substance P, prostaglandins, interferons, thrombospondin 1), activated macrophages have the capability to influence each phase of the angiogenic process, such as alterations of the local extracellular matrix, induction of endothelial cells to migrate or proliferate, and inhibition of vascular growth with formation of differentiated capillaries. This review describes macrophage physiology and the influence of macrophage secretory products on the different phases of angiogenesis in vitro and in vivo. J. Lcukoc. Biol. 55: 410–422; 1994.

[1]  R. Kendall,et al.  Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  L. Mucke,et al.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Polverini,et al.  Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1. , 1993, The American journal of pathology.

[4]  P. Polverini,et al.  Role of the macrophage in the positive and negative regulation of wound neovascularization. , 1993, Behring Institute Mitteilungen.

[5]  T. McCaffrey,et al.  Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. , 1993, The Journal of biological chemistry.

[6]  L. Schook,et al.  Mechanisms generating functionally heterogeneous macrophages: chaos revisited , 1993, Journal of leukocyte biology.

[7]  S. Nakamura,et al.  Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[8]  Recombinant truncated thrombospondin-1 monomer modulates endothelial cell plasminogen activator inhibitor 1 accumulation and proliferation in vitro. , 1993, Biochemical and biophysical research communications.

[9]  N. Sato,et al.  Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. , 1993, The American journal of pathology.

[10]  K. Kohno,et al.  Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro. , 1993, Experimental cell research.

[11]  D. Slaaf,et al.  Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. , 1993, The American journal of physiology.

[12]  S. Haskill,et al.  Signal transduction from the extracellular matrix , 1993, The Journal of cell biology.

[13]  M. Goebeler,et al.  Expression and complex assembly of calcium‐binding proteins MRP8 and MRP14 during differentiation of murine myelomonocytic cells , 1993, Journal of leukocyte biology.

[14]  Jan Tavernier,et al.  Human TNF mutants with selective activity on the p55 receptor , 1993, Nature.

[15]  L. Orci,et al.  Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. , 1993, Experimental cell research.

[16]  G. Haines,et al.  Localization of the angiogenesis inhibitor thrombospondin in human synovial tissues. , 1993, Pathobiology : journal of immunopathology, molecular and cellular biology.

[17]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[18]  R. Strieter,et al.  Interleukin-8. A corneal factor that induces neovascularization. , 1992, The American journal of pathology.

[19]  R. Pugh-Humphreys Macrophage-neoplastic cell interactions: implications for neoplastic cell growth. , 1992, FEMS microbiology immunology.

[20]  E. Keshet,et al.  In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. N. Schullinger Interferon alfa-2a therapy for life-threatening hemangiomas of infancy , 1992 .

[22]  H. Dvorak,et al.  Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing , 1992, The Journal of experimental medicine.

[23]  Georg Breier,et al.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.

[24]  T. Hada,et al.  Excessive production of transforming growth-factor β1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth , 1992 .

[25]  K. Schulze-Osthoff,et al.  A comparative study on the effects of tumor necrosis factor‐α (TNF‐α), human angiogenic factor (h‐AF) and basic fibroblast growth factor (bFGF) on the chorioallantoic membrane of the chick embryo , 1992, The Anatomical record.

[26]  W. Thompson,et al.  Angiogenic activity of fibrin degradation products is located in fibrin fragment E , 1992, The Journal of pathology.

[27]  D. Rifkin,et al.  Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity , 1992, The Journal of cell biology.

[28]  M. Goebeler,et al.  The calcium‐binding proteins MRP8 and MRP14 form a membrane‐associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions , 1992, European journal of immunology.

[29]  S D Prionas,et al.  Dual role of tumor necrosis factor-alpha in angiogenesis. , 1992, The American journal of pathology.

[30]  I. Morita,et al.  Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells. , 1992, Atherosclerosis.

[31]  H. Dvorak,et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.

[32]  E. Kohner,et al.  A study of the Effects of Angiotensins 1, 2, 3 and Bradykinin on the Replication of Bovine Retinal Capillary Endothelial Cells and Pericytes , 1992, European journal of ophthalmology.

[33]  J. Winer,et al.  Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. , 1992, The Journal of clinical investigation.

[34]  M. Klagsbrun,et al.  Macrophages secrete a heparin-binding inhibitor of endothelial cell growth. , 1991, Microvascular research.

[35]  C. Sorg Macrophages in acute and chronic inflammation. , 1991, Chest.

[36]  T. Kooistra,et al.  Regulation of plasminogen activator production by endothelial cells: role in fibrinolysis and local proteolysis. , 1991, International journal of radiation biology.

[37]  M. Iruela-Arispe,et al.  Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Sporn,et al.  Cytokines in context , 1991, The Journal of cell biology.

[39]  J. Roth,et al.  Cellular events associated with inflammatory angiogenesis in the mouse cornea. , 1991, The American journal of pathology.

[40]  A. Mantovani,et al.  In vitro and in vivo activation of endothelial cells by colony-stimulating factors. , 1991, The Journal of clinical investigation.

[41]  Julie H. Campbell,et al.  THE MACROPHAGE AS AN INITIATOR OF ATHEROSCLEROSIS , 1991, Clinical and experimental pharmacology & physiology.

[42]  V. Srikantan,et al.  Differential effects of interferon gamma and alpha on in vitro model of angiogenesis , 1991, Journal of cellular physiology.

[43]  B. Meyrick,et al.  Effects of recombinant tumor necrosis factor-alpha on cultured pulmonary artery and lung microvascular endothelial monolayers. , 1991, The American journal of pathology.

[44]  M. Bhargava,et al.  Interleukin-6 stimulates motility of vascular endothelium. , 1991, EXS.

[45]  C. Maggi,et al.  Substance P induces migration of capillary endothelial cells: a novel NK-1 selective receptor mediated activity. , 1991, Life sciences.

[46]  K. Schulze-Osthoff,et al.  Macrophage-derived angiogenesis factors. , 1991, Pharmacology & therapeutics.

[47]  A. Koch,et al.  Monoclonal antibodies detect monocyte/macrophage activation and differentiation antigens and identify functionally distinct subpopulations of human rheumatoid synovial tissue macrophages. , 1991, The American journal of pathology.

[48]  W. Newman,et al.  Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro. , 1991, The American journal of pathology.

[49]  N. Sato,et al.  Actions of TNF and IFN-gamma on angiogenesis in vitro. , 1990, The Journal of investigative dermatology.

[50]  M. Detmar,et al.  Effects of rIFN alpha, beta, and gamma on the morphology, proliferation, and cell surface antigen expression of human dermal microvascular endothelial cells in vitro. , 1990, The Journal of investigative dermatology.

[51]  T. Maione,et al.  Development of angiogenesis inhibitors for clinical applications. , 1990, Trends in pharmacological sciences.

[52]  C. Maggi,et al.  Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. , 1990, Microvascular research.

[53]  J. Roth,et al.  Immunohistochemical detection of bFGF and TNF-alpha in the course of inflammatory angiogenesis in the mouse cornea. , 1990, American Journal of Pathology.

[54]  K. Bost,et al.  Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide. , 1990, Immunology.

[55]  M. L. Le Beau,et al.  A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[56]  D. Bani,et al.  Interleukin 1 is an autocrine regulator of human endothelial cell growth. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Madri,et al.  Influence of the angiotensin system on endothelial and smooth muscle cell migration. , 1990, The American journal of pathology.

[58]  E. Vollmer,et al.  In situ detection of basic fibroblast growth factor by highly specific antibodies. , 1990, The American journal of pathology.

[59]  H. Moses,et al.  The cell biology of transforming growth factor β , 1990 .

[60]  J. Wautier,et al.  Identification of an endothelial cell growth-inhibitory activity produced by human monocytes. , 1990, Experimental cell research.

[61]  T. Hirano,et al.  AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[62]  B. Zetter,et al.  Tumor interactions with the vasculature: angiogenesis and tumor metastasis. , 1990, Biochimica et biophysica acta.

[63]  L. Sachs,et al.  Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[64]  G. Gray,et al.  Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. , 1990, Science.

[65]  S. Ryan,et al.  Activated macrophages in experimental subretinal neovascularization. , 1990, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[66]  P. Vassalli,et al.  Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. , 1990, The American journal of pathology.

[67]  H. Liu,et al.  Interactions between fibrin, collagen and endothelial cells in angiogenesis. , 1990, Advances in experimental medicine and biology.

[68]  C. Heldin,et al.  B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[69]  D. Connolly,et al.  Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.

[70]  K. Sueishi,et al.  A role of fibrinolytic activity in angiogenesis. Quantitative assay using in vitro method. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[71]  K. Nishikawa,et al.  Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[72]  W. Calhoun,et al.  Studies of bronchoalveolar lavage cells and fluids in pulmonary sarcoidosis. I. Enhanced capacity of bronchoalveolar lavage cells from patients with pulmonary sarcoidosis to induce angiogenesis in vivo. , 1989, The American review of respiratory disease.

[73]  D. Connolly,et al.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. , 1989, The Journal of clinical investigation.

[74]  D. J. Strydom,et al.  The odyssey of angiogenin: a protein that induces blood vessel growth. , 1989, Analytical chemistry.

[75]  H. Dvorak,et al.  Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumors and to many other types of disease. , 1989, The American review of respiratory disease.

[76]  J. Madri,et al.  Effect of Platelet Factors on Migration of Cultured Bovine Aortic Endothelial and Smooth Muscle Cells , 1989, Circulation research.

[77]  Donald E. Ingber,et al.  How does extracellular matrix control capillary morphogenesis? , 1989, Cell.

[78]  S. Kumar,et al.  The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. , 1989, Experimental cell research.

[79]  D. Rifkin,et al.  Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.

[80]  D E Ingber,et al.  Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix , 1989, The Journal of cell biology.

[81]  Peter J. Polverini,et al.  Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene , 1989, Cell.

[82]  A. Mantovani,et al.  Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate , 1989, Nature.

[83]  H. Hansson,et al.  Transient expression of insulin-like growth factor I immunoreactivity by vascular cells during angiogenesis. , 1989, Experimental and molecular pathology.

[84]  D. Rifkin,et al.  In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases , 1989, The Journal of cell biology.

[85]  S. Dower,et al.  Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. , 1989, Science.

[86]  S. Nilsson,et al.  Vasodynamic and angiogenic effects of eicosanoids in the eye. , 1989, Progress in clinical and biological research.

[87]  C. Heldin,et al.  Rat brain capillary endothelial cells express functional PDGF B-type receptors. , 1989, Growth factors.

[88]  R. Crystal,et al.  Alveolar macrophages release an insulin-like growth factor I-type molecule. , 1988, The Journal of clinical investigation.

[89]  J. Rosenbaum,et al.  Ocular inflammatory effects of intravitreally-injected tumor necrosis factor. , 1988, The American journal of pathology.

[90]  P. Vaupel,et al.  Purified monocyte-derived angiogenic substance (angiotropin) induces controlled angiogenesis associated with regulated tissue proliferation in rabbit skin. , 1988, The Journal of clinical investigation.

[91]  D. Rifkin,et al.  Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis , 1988, The Journal of cell biology.

[92]  N. Sato,et al.  Inhibition of in vitro angiogenesis by lymphotoxin and interferon-gamma. , 1988, Biochemical and biophysical research communications.

[93]  K. Osthoff,et al.  Immunolocalization of an angiogenic factor (HAF) in normal, inflammatory and tumor tissues , 1988, International journal of cancer.

[94]  M J Banda,et al.  Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. , 1988, Science.

[95]  D. Moscatelli,et al.  The development of a quantitative RIA for basic fibroblast growth factor using polyclonal antibodies against the 157 amino acid form of human bFGF. The identification of bFGF in adherent elicited murine peritoneal macrophages. , 1988, Journal of immunological methods.

[96]  M. Sporn,et al.  Induction of transforming growth factor-α in activated human alveolar macrophages , 1988, Cell.

[97]  C. Perez,et al.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.

[98]  J. Madri,et al.  Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix , 1988, The Journal of cell biology.

[99]  R. Steinman Cytokines amplify the function of accessory cells. , 1988, Immunology letters.

[100]  T. Doetschman,et al.  Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. , 1988, Development.

[101]  P. Sehgal,et al.  Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6). , 1988, Science.

[102]  M. Cybulsky,et al.  Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury. , 1987, The American journal of pathology.

[103]  E. Appella,et al.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[104]  R. G. Clerc,et al.  Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis , 1987, Nature.

[105]  J. Wissler,et al.  Purified monocyte‐derived angiogenic substance (angiotropin) stimulates migration, phenotypic changes, and “tube formation” but not proliferation of capillary endothelial cells in vitro , 1987, Journal of cellular physiology.

[106]  Ana D. Lopez,et al.  An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. , 1987, Biochemical and biophysical research communications.

[107]  M. Sporn,et al.  Expression and secretion of type beta transforming growth factor by activated human macrophages. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[108]  B. Overwien,et al.  Purification and characterization of a novel human angiogenic factor (h-AF). , 1987, Biochemical and biophysical research communications.

[109]  W. Birchmeier,et al.  Inhibitory action of transforming growth factor beta on endothelial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[110]  W. Risau,et al.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[111]  J. Vilček,et al.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[112]  R. Friesel,et al.  Inhibition of endothelial cell proliferation by gamma-interferon , 1987, The Journal of cell biology.

[113]  C. Nathan,et al.  Secretory products of macrophages. , 1987, The Journal of clinical investigation.

[114]  D. Belin,et al.  Plasminogen activator-specific inhibitors produced by human monocytes/macrophages , 1987, The Journal of experimental medicine.

[115]  R. Auerbach,et al.  Macrophage-Induced Neovascularization in the Mouse Eye: Correlation with Other in vivo and in vitro Tests of Angiogenesis , 1987 .

[116]  H. Shepard,et al.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.

[117]  Harold L. Moses,et al.  Production and auto-induction of transforming growth factor-α in human keratinocytes , 1987, Nature.

[118]  H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[119]  L. Orci,et al.  Basic fibroblast growth factor induces angiogenesis in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[120]  N. Sato,et al.  Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. , 1986, Journal of the National Cancer Institute.

[121]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[122]  T. K. Hunt,et al.  Effect of lactate, pyruvate, and pH on secretion of angiogenesis and mitogenesis factors by macrophages. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[123]  A. Koch,et al.  Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. , 1986, Arthritis and rheumatism.

[124]  B. Beutler,et al.  Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.

[125]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[126]  N. Roberts,et al.  Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity , 1986, The Journal of experimental medicine.

[127]  A. Koch,et al.  Induction of Neovascularization by Activated Human Monocytes , 1986, Journal of leukocyte biology.

[128]  Gary R. Grotendorst,et al.  Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity , 1986, Nature.

[129]  J. W. Moore,et al.  Comparison of the neovascular effects of stimulated macrophages and neutrophils in autologous rabbit corneas. , 1985, The American journal of pathology.

[130]  Andrew D. Luster,et al.  γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins , 1985, Nature.

[131]  I. Hampson,et al.  Angiogenesis induced by degradation products of hyaluronic acid. , 1985, Science.

[132]  R. Crystal,et al.  Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. , 1985, The Journal of clinical investigation.

[133]  P. Polverini,et al.  Induction of Neovascularization and Nonlymphoid Mesenchymal Cell Proliferation by Macrophage Cell Lines , 1985, Journal of leukocyte biology.

[134]  C. Kahn,et al.  Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. , 1985, The Journal of clinical investigation.

[135]  L. Fernandez,et al.  Neovascularization produced by angiotensin II. , 1985, The Journal of laboratory and clinical medicine.

[136]  S. Vogel,et al.  Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons. , 1985, Journal of immunology.

[137]  P. Morméde,et al.  Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. , 1985, Biochemical and biophysical research communications.

[138]  W. Thompson,et al.  Fibrin degradation and angiogenesis: Quantitative analysis of the angiogenic response in the chick chorioallantoic membrane , 1985, The Journal of pathology.

[139]  E. Jaffe,et al.  Monocytes and macrophages synthesize and secrete thrombospondin. , 1985, Blood.

[140]  P. Polverini,et al.  Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[141]  H. Zauberman,et al.  Topical indomethacin effect on neovascularisation of the cornea and on prostaglandin E2 levels. , 1984, The British journal of ophthalmology.

[142]  T. K. Hunt,et al.  Studies on inflammation and wound healing: angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages. , 1984, Surgery.

[143]  J. Wilson,et al.  Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[144]  T. K. Hunt,et al.  Oxygen tension regulates the expression of angiogenesis factor by macrophages. , 1983, Science.

[145]  Stuart K Williams,et al.  Capillary endothelial cell cultures: phenotypic modulation by matrix components , 1983, The Journal of cell biology.

[146]  R. Sullivan,et al.  The synthesis and secretion of granulocyte-monocyte colony-stimulating activity (CSA) by isolated human monocytes: kinetics of the response to bacterial endotoxin. , 1983, Journal of immunology.

[147]  P. Gullino,et al.  Role of prostaglandin E1 and copper in angiogenesis. , 1982, Journal of the National Cancer Institute.

[148]  R. Langer,et al.  Plasminogen activator (urokinase) causes vascularization of the cornea. , 1982, Investigative ophthalmology & visual science.

[149]  H. Fleit,et al.  Production of interferon by in vitro derived bone marrow macrophages. , 1981, Cellular immunology.

[150]  D. Jones,et al.  Mechanism of the induction of angiogenesis by human neoplastic lymphoid tissue: Studies employing bovine aortic endothelial cells in vitro , 1980, The Journal of pathology.

[151]  D. Jones,et al.  Mechanism of the induction of angiogenesis by human neoplastic lymphoid tissue: Studies on the chorioallantoic membrane (CAM) of the chick embryo , 1980, The Journal of pathology.

[152]  B. Zetter,et al.  Inhibition of cell motility by interferon. , 1980, Science.

[153]  J. Filkins Endotoxin-enhanced secretion of macrophage insulin-like activity. , 1980, Journal of the Reticuloendothelial Society.

[154]  E. Silverstein,et al.  Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[155]  T. K. Hunt,et al.  Stimulation of wound blood vessel growth by wound macrophages. , 1979, The Journal of surgical research.

[156]  T. K. Hunt,et al.  The proliferative response in vitro of vascular endothelial and smooth muscle cells exposed to wound fluids and macrophages , 1978, Journal of cellular physiology.

[157]  D. Benezra Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants. , 1978, American journal of ophthalmology.

[158]  E. Silverstein,et al.  Angiotensin-converting enzyme in macrophages and Freund's adjuvant granuloma. , 1978, Israel journal of medical sciences.

[159]  E. Unanue,et al.  Activated macrophages induce vascular proliferation , 1977, Nature.

[160]  F. Kuehl,et al.  Macrophages synthesise and release prostaglandins in response to inflammatory stimuli , 1977, Nature.

[161]  J. Folkman,et al.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. , 1977, Microvascular research.

[162]  R. Evans Effect of X-irradiation on host-cell infiltration and growth of a murine fibrosarcoma. , 1977, British Journal of Cancer.

[163]  C. Sorg,et al.  Lymphokine‐induced secretion of plasminogen activator by murine macrophages , 1977, European journal of immunology.

[164]  R. Cotran,et al.  Endothelial proliferation in the delayed hypersensitivity reaction: an autoradiographic study. , 1977, Journal of immunology.

[165]  C. Fromer,et al.  An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. II. Studies on the effect of leukocytic elimination on corneal vascularization. , 1975, The American journal of pathology.

[166]  R. Auerbach,et al.  Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction , 1975, The Journal of experimental medicine.

[167]  R. Ross,et al.  The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.

[168]  A. Lobuglio,et al.  Human Blood Monocytes: Stimulators of Granulocyte and Mononuclear Colony Formation in vitro , 1972, Science.

[169]  M. Burleigh,et al.  Role of granulocyte collagenase in collagen degradation. , 1972, The American journal of pathology.

[170]  R. Ross,et al.  The neutrophilic leukocyte in wound repair a study with antineutrophil serum. , 1972, The Journal of clinical investigation.